Mandadi Tilak's Form 4 filing
CVS Health Corp (CVS) · filed May 11, 2026
- Accession no.
- 0000064803-26-000056
- Filed
- May 11, 2026
- Trade date
- May 8, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $6.23M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mandadi TilakCIK 0001872827 | Officer (EVP, Chief Exp & Tech Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | Common Stock | SSaleDisposed | −69,551 | $89.58F1 | −$6,230,378.58 | 10,133 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
All shares sold at an Average price between $89.30 and $89.81.
Referenced by the price of 1 transaction in Table I.